Close Menu

NEW YORK (GenomeWeb) – GeneNews reported today a 78 percent decrease in second quarter revenues, reflecting a drop off in sales of its ColonSentry colorectal cancer blood test and other diagnostics.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.